Antheia
Jong Wu is an experienced scientist with a robust background in analytical chemistry and process analytics. Currently serving as a Scientist in Process Analytics/QC at Antheia, Inc. since June 2022, Jong Wu previously held positions at Nektar Therapeutics as SRA/Scientist, specializing in biologics, and at Achaogen as an Analytical Chemist, where responsibilities included optimizing analytical methods and conducting drug product compatibility studies. Other notable roles include Analytical Research Scientist at Carbylan Therapeutics, Analytical Chemist at Transcept Pharmaceuticals, and Associate Scientist at Alza (Johnson & Johnson). Early career experiences include work as a Research Associate at Bertek Pharmaceuticals, Development Scientist at Litmus Concepts, and Field Chemist at Laidlaw Environment Services. Jong Wu holds a degree in Chemistry and Biochemistry from San Jose State University.
This person is not in any teams
Antheia
Antheia is unlocking the medicinal power of nature. Its synthetic biology platform surpasses the limits of conventional drug discovery and manufacturing through a novel approach to whole cell engineering reconstructing complex molecules in yeast to bring to market next generation plant inspired medicines.